Special Issue "Apoptosis and Autophagy: The Double Edge in Cancer Development and Progression and in Other Human Diseases 2.0"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (28 February 2020).
Interests: cancer; miRNAs; nanotechnology; drug delivery; nano sensors; long non-coding RNA; signal transduction; isoprenylation and cancer; aminobisphosphonates; glioblastoma; prostate cancer; hepatocellular cancer; signal transduction; Ras; interferons
Special Issues and Collections in MDPI journals
Interests: aging, oxidative stress, nitric oxide, endothelial cells, endothelial progenitor cells, angiogenesis, inflammation, cell senescence, apoptosis, atherosclerosis, diabetes, endothelial dysfunction, sirtuins and cardiovascular disease; natural products, betaines, health, bioactive compounds, free radicals, antioxidants, ergothioneine; cell cycle, cancer-related biochemical pathways, cell proliferation, senescence, cancer cell death, epigenetic regulation, sirtuins and cancer
Special Issues and Collections in MDPI journals
Special Issue in International Journal of Molecular Sciences: Sirtuins and Epigenetics in Aging and Diseases
Special Issue in J — Multidisciplinary Scientific Journal: Atherosclerosis: Molecular Mechanisms and Therapeutic Advances
Special Issue in Molecules: Recent Advances in Natural Products Chemistry Related to Metabolites and Microbiomes
Special Issue in International Journal of Molecular Sciences: Effects of Prediabetes on the Progression of Cardiovascular Diseases: When Should We Care?
We are pleased to announced the continuation of our Special Issue “Apoptosis and Autophagy: The Double Edge in Cancer Development and Progression and in Other Human Diseases”, with a second edition.
The mechanisms of cell death have a pivotal role in the determination of the fate of normal and cancer cells in a multicellular organism. The disruption of these mechanisms is at the core of the development of inflammatory and tumor diseases, and knowledge of the molecular components altered in specific illnesses can be useful in the design of new therapeutic strategies for the treatment of human cancers as well as of inflammatory diseases. Two of the most known cell death mechanisms are apoptosis and autophagy, which are differently-involved in the regulation of tumor cell proliferation and metastasization. These mechanisms are often opposite, and autophagy is described as an escape mechanism from apoptotic occurrence, representing a protective effect of tumor cells to anti-cancer agents or hypoxic conditions, both of which are deleterious for cancer progression. On the other hand, some anti-cancer agents can induce autophagy during the repression of tumor proliferation. In this way, autophagy can become a marker of cancer response to treatment. The existence of specific tumor conditions can determine the functional role of autophagy in cancer tissues. The interaction between autophagy and apoptosis occurs through the cross-talk of the respective molecular mechanisms that are able to influence each other in a tunable way. A role for apoptosis and autophagy in the regulation of normal tissue development and differentiation is also emerging. Therefore, apoptosis and autophagy also regulate the physiological mechanisms of several organs (i.e., liver and ovary), and are involved in the occurrence of several diseases, based on either a development defect or a chronic inflammatory status. The intervention on the programmed cell death with specific agents can be a new strategy for the treatment of these kinds of diseases.
This Issue of the International Journal of Molecular Sciences will focus on the recent advances in “Apoptosis and Autophagy: The Double Edge in Cancer Development and Progression and in Other Human Diseases 2.0”, including new insights into the molecular mechanisms of apoptosis, autophagy, and other programmed cell death mechanisms (i.e., senescence), and their correlations with the control of cancer growth, metastasization, tissue development, and inflammation. Moreover, emerging data on the natural or synthetic modulators of apoptosis and autophagy in relation to new therapeutic strategies are welcome.
Prof. Dr. Michele Caraglia
Prof. Dr. Maria Luisa Balestrieri
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- long non-coding RNAs